Formicin – a novel broad-spectrum two-component lantibiotic produced by Bacillus paralicheniformis APC 1576
Open Access
- 1 September 2016
- journal article
- research article
- Published by Microbiology Society in Microbiology
- Vol. 162 (9) , 1662-1671
Abstract
Bacteriocins represent a rather underutilized class of antimicrobials despite often displaying activity against many drug-resistant pathogens. Lantibiotics are a post-translationally modified class of bacteriocins, characterized by the presence of lanthionine and methyllanthionine bridges. In this study, a novel two-peptide lantibiotic was isolated and characterized. Formicin was isolated from Bacillus paralicheniformis APC 1576, an antimicrobial-producing strain originally isolated from the intestine of a mackerel. Genome sequencing allowed for the detection of the formicin operon and, from this, the formicin structural genes were identified, along with those involved in lantibiotic modification, transport and immunity. The identified bacteriocin was subsequently purified from the bacterial supernatant. Despite the degree of conservation seen amongst the entire class of two-peptide lantibiotics, the formicin peptides are unique in many respects. The formicin α peptide is far less hydrophobic than any of the equivalent lantibiotics, and with a charge of plus two, it is one of the most positively charged α peptides. The β peptide is unique in that it is the only such peptide with a negative charge due to the presence of an aspartic acid residue in the C-terminus, possibly indicating a slight variation to the mode of action of the bacteriocin. Formicin also displays a broad spectrum of inhibition against Gram-positive strains, inhibiting many clinically relevant pathogens such as Staphylococcus aureus, Clostridium difficile and Listeria monocytogenes. The range of inhibition displayed against many important pathogens indicates a potential therapeutic use against such strains where antibiotic resistance is such a growing concern.Keywords
This publication has 35 references indexed in Scilit:
- Biosynthesis and Transport of the Lantibiotic Mutacin 1140 Produced by Streptococcus mutansJournal of Bacteriology, 2015
- Bacteriocins — a viable alternative to antibiotics?Nature Reviews Microbiology, 2012
- Lantibiotics: How do producers become self-protected?Journal of Biotechnology, 2012
- Identification of a Novel Two-Peptide Lantibiotic, Lichenicidin, following Rational Genome Mining for LanM ProteinsApplied and Environmental Microbiology, 2009
- Production of the Novel Two-Peptide Lantibiotic Lichenicidin by Bacillus licheniformis DSM 13PLOS ONE, 2009
- Structure-Activity Relationship Studies of the Two-Component Lantibiotic HaloduracinChemistry & Biology, 2008
- Complete alanine scanning of the two‐component lantibiotic lacticin 3147: generating a blueprint for rational drug designMolecular Microbiology, 2006
- BAGEL: a web-based bacteriocin genome mining toolNucleic Acids Research, 2006
- Mutational analysis and membrane-interactions of the β-sheet-like N-terminal domain of the pediocin-like antimicrobial peptide sakacin PBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2006
- Mersacidin, a new antibiotic from Bacillus Fermentation, isolation, purification and chemical characterization.The Journal of Antibiotics, 1992